Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 10, 2024Prospects in Pharmaceutical SciencesOpen Access

Role of calcitonin gene-related peptide (CGRP) receptor antagonist in acute and preventive treatment of migraine.

View Full Paper
Ask AI
Bookmark
Share

Authors

MDMichał DackaMSMateusz SobczykPDPaulina Dąbrowska

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Dacka et al. (2024) studied this question.

synapsesocial.com/papers/68e60ceeb6db6435875a0952https://doi.org/10.56782/pps.206
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Drug-related side effects and adverse reactions in the treatment of migraine: a bibliometric and visual analysis2024 · 9 citations
  2. 2Rimegepant: A Review in the Acute Treatment and Preventive Treatment of Migraine2023 · 58 citations
  3. 3Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition2018 · 10,870 citations
  4. 4NEUROGENIC INFLAMMATION AND MIGRAINE: IMPLICATIONS FOR THE THERAPEUTICS2005 · 140 citations